{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:48:45Z","timestamp":1790077725179,"version":"4.0.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136845","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T14:30:35Z","timestamp":1440772235000},"page":"e0136845","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Ton","family":"van Agthoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert C. J.","family":"Dorssers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert H. J.","family":"Looijenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Christgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.breast.2007.03.004","article-title":"Endocrine therapy for breast cancer: an overview","volume":"16","author":"KL Cheung","year":"2007","journal-title":"Breast"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"J Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"issue":"20","key":"ref3","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1002\/cncr.27518","article-title":"Prognostic value of estrogen receptor alpha and progesterone receptor conversion in distant breast cancer metastases","volume":"118","author":"LD Hoefnagel","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrc2713","article-title":"Biological determinants of endocrine resistance in breast cancer","volume":"9","author":"EA Musgrove","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.03.016","article-title":"Pathways to tamoxifen resistance","volume":"256","author":"RB Riggins","year":"2007","journal-title":"Cancer Lett"},{"issue":"1\u20133","key":"ref6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2012.11.071","article-title":"Tamoxifen resistance: from bench to bedside","volume":"717","author":"M Droog","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2008.17.1462","article-title":"Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance","volume":"27","author":"T van Agthoven","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1541-7786.MCR-05-0156","article-title":"Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells","volume":"4","author":"D Meijer","year":"2006","journal-title":"Mol Cancer Res"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/sj.bjc.6605884","article-title":"Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer","volume":"103","author":"MF Godinho","year":"2010","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/jcp.22503","article-title":"Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells","volume":"226","author":"M Godinho","year":"2011","journal-title":"J Cell Physiol"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.27489","article-title":"Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines","volume":"131","author":"T van Agthoven","year":"2012","journal-title":"Int J Cancer"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/humrep\/des412","article-title":"Breast-cancer anti-estrogen resistance 4 (BCAR4) encodes a novel maternal-effect protein in bovine and is expressed in the oocyte of humans and other non-rodent mammals","volume":"28","author":"L Angulo","year":"2013","journal-title":"Hum Reprod"},{"issue":"Database issue","key":"ref13","doi-asserted-by":"crossref","first-page":"D983","DOI":"10.1093\/nar\/gks1099","article-title":"LncRNADisease: a database for long-non-coding RNA-associated diseases","volume":"41","author":"G Chen","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"ref14","doi-asserted-by":"crossref","first-page":"D749","DOI":"10.1093\/nar\/gkt1196","article-title":"Ensembl 2014","volume":"42","author":"P Flicek","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/path.2495","article-title":"Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer","volume":"217","author":"M Christgen","year":"2009","journal-title":"J Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/labinvest.2012.126","article-title":"IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes","volume":"92","author":"M Christgen","year":"2012","journal-title":"Lab Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2011.09.038","article-title":"ABCB1\/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells","volume":"315","author":"T Krech","year":"2012","journal-title":"Cancer Lett"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/cas.12276","article-title":"IPH-926 lobular breast cancer cells are triple-negative but their microarray profile uncovers a luminal subtype","volume":"104","author":"M Christgen","year":"2013","journal-title":"Cancer Sci"},{"issue":"41","key":"ref19","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1038\/sj.onc.1205794","article-title":"Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR\/erbB2 and downstream Erk1\/2 and AKT pathways","volume":"21","author":"W Xia","year":"2002","journal-title":"Oncogene"},{"issue":"10","key":"ref20","first-page":"3352","article-title":"Establishment and characterization of three new continuous cell lines derived from human breast carcinomas","volume":"38","author":"LW Engel","year":"1978","journal-title":"Cancer Res"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/ijc.23806","article-title":"KAI1\/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer","volume":"123","author":"M Christgen","year":"2008","journal-title":"Int J Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/gcc.22007","article-title":"Oncogenic PIK3CA mutations in lobular breast cancer progression","volume":"52","author":"M Christgen","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"MC Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"MC Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"31","key":"ref25","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"AC Wolff","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.2012.351","article-title":"BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib","volume":"107","author":"MF Godinho","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"S Droufakou","year":"2001","journal-title":"Int J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13058-015-0542-y","article-title":"Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA","volume":"17","author":"EL Hayes","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-009-0460-8","article-title":"Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines","volume":"121","author":"A Hollestelle","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10549-010-1329-6","article-title":"The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort","volume":"126","author":"FO Ademuyiwa","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-13-0295","article-title":"Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations","volume":"19","author":"JS Ross","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"e79901","DOI":"10.1371\/journal.pone.0079901","article-title":"Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment Method","volume":"8","author":"Y Bai","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.10.013","article-title":"lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals","volume":"159","author":"Z Xing","year":"2014","journal-title":"Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T21:49:09Z","timestamp":1540331349000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136845"}},"subtitle":[],"editor":[{"given":"Yuan-Soon","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136845","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}